Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion – Wall Street Journal
Wall Street Journal |
Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion
Wall Street Journal Immunotherapy, or immune-cell therapy, describes a range of treatments that harness a patient's own immune system to target cancer. The approach doesn't work in all patients, but has worked well against hard-to-treat cancers in some and has become the … Eli Lilly acquires small biotech for $1.6B to strengthen cancer immunotherapy pipeline Lilly (LLY) to Acquire ARMO BioSciences (ARMO) for $50/Share |
